e-learning
resources
Milan 2017
Sunday, 10.09.2017
Current challenges in COPD evaluation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
M. Bafadhel (Oxford, United Kingdom)
Source:
International Congress 2017 – Current challenges in COPD evaluation
Session:
Current challenges in COPD evaluation
Session type:
Poster Discussion
Number:
394
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bafadhel (Oxford, United Kingdom). Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis. 394
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Sputum neutrophil elastase and inhaled antibiotic response in bronchiectasis: a post-hoc analysis of the ORBIT-4 trial
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021
Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD?
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Cytogenetic analysis in peripheral blood lymphocytes from asthmatic patients with different severity
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021
Proteomic analysis of T-lymphocytes in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 550s
Year: 2006
Comparison of blood and sputum analysis in evaluation of eosinophilic COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Treatment response in COPD: does FEV
1
say it all? A
post hoc
analysis of the CRYSTAL study
Source: ERJ Open Res, 5 (1) 00243-2018; 10.1183/23120541.00243-2018
Year: 2019
Correlation of biological markers of inflammation in peripheral blood with bronchoprovocative testing with histamine in patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 287s
Year: 2004
The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Clinical analysis of acute exacerbation of COPD cases with increased eosinophilic granulocytes in peripheral blood
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis
Source: Eur Respir J 2014; 44: 789-791
Year: 2014
Flow cytometric assessment of sputum lymphocyte cytokine profiles in patients with asthma and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 316s
Year: 2001
Analysis of cytogenetic alterations in peripheral blood lymphocytes from asthmatic patients treated with oral corticosteroids
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
Efficacy of aclidinium/formoterol: pooled post hoc analysis of patients naïve to COPD maintenance therapy
Source: International Congress 2017 – COPD management
Year: 2017
LATE-BREAKING ABSTRACT: Blood eosinophils (EOS) are a biomarker of COPD exacerbation reduction with inhaled corticosteroids (ICS): An across-trials model-based approach
Source: International Congress 2016 – New and old therapies for chronic lung diseases
Year: 2016
Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD
Source: Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019
Year: 2020
Effect of extrafine medium strength (MS) ICS-containing triple therapy on exacerbations in asthmatics with persistent airflow limitation: A post-hoc analysis of the TRIMARAN study
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019
Effect of indacaterol/glycopyrronium (IND/GLY) vs salmeterol/fluticasone (SFC) on moderate or severe COPD exacerbations and lung function based on baseline blood eosinophil counts: Results from the FLAME study
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept